Delivery Order SPE2DB24D2003-SPE2DB25FXNA3
Award Date 9/19/25
Potential Completion Date 9/22/25
Potential Value $6.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,826.35 to AmerisourceBergen Drug Corp for EXFORGE 5-160 MG tablets (30-count supply) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, which runs through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $6,724.20 to AmerisourceBergen Drug Corp for EXFORGE HCT 10-160-25 mg tablets (30-count supply) on September 12, 2025, with an ultimate completion date of September 15, 2025. This delivery order represents a firm fixed price transaction under a non-set-aside competitive procurement and will be performed at the vendor's location in Conshohocken, Pennsylvania. EXFORGE HCT is a combination hypertension medication, reflecting the...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $2,001.95 to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30-count) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price contract is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $15,095.94 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Exforge 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order...
- The Defense Logistics Agency awarded a $6,588.62 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count units). This firm fixed price delivery order, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $5,673.51 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. Exforge is a combination antihypertensive medication used to treat...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a contract ceiling value of $2,250.48. This firm fixed-price delivery order, with an ultimate completion date of September 22, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, leveraging the company's...
- The Defense Logistics Agency awarded a $16,889.00 delivery order to AmerisourceBergen Drug Corp for 30-count tablets of Exforge 10-320 mg, a combination antihypertensive medication. This competitively awarded, firm fixed-price contract was executed on July 23, 2025, with an ultimate completion date of July 24, 2025, and represents a child delivery order under a larger indefinite delivery contract vehicle. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide EXFORGE 10-320 MG TABLET 30S for a potential value of $1,504.44. The contract has a completion date of February 20, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31,...